Page 10 | Certara

On-Demand Webinar

ToxStudio®: In silico tools to accelerate toxicology assessments

Watch to explore ToxStudio—in silico toxicology platform designed to address key preclinical safety challenges.

CertaraAugust 19, 2025

On-Demand Webinar

Certara IQ™: The Scalable AI-Powered QSP Software

Discover how Certara's AI-powered QSP modeling software, Certara IQ is overcoming challenges in drug development…

CertaraAugust 19, 2025

On-Demand Webinar

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Watch Certara’s RAPS-sponsored on-demand webinar to learn how automation and expert strategies simplify patient narrative…

CertaraAugust 18, 2025

Case Study

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

Find out how Certara helped a small biotech achieve on-time IND and CTA submissions with…

CertaraAugust 18, 2025

Conference

BioTechX US 2025

– – Booth

Simona ColucciAugust 15, 2025

Blog

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Streamline your SDTM mapping with Pinnacle 21 Enterprise. Discover how innovation and efficiency enhance data…

CertaraAugust 13, 2025

Publication

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Explore comprehensive population pharmacokinetic analyses of belantamab mafodotin, evaluating both monotherapy and combination regimens in…

CertaraAugust 13, 2025

Publication

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Explore updated results from the Phase 3 TROPiCS-02 trial of Sacituzumab Govitecan in advanced HR+/HER2–…

CertaraAugust 13, 2025

On-Demand Webinar

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Access our on-demand webinar to explore the key differences between eCTD 4.0 and eCTD 3.2.2.…

CertaraAugust 11, 2025

Blog

Regulatory Operations Best Practices for Health Canada Submissions

Health Canada submissions now require eCTD/CESG; regulatory operations expert support can streamline the process and…

CertaraAugust 11, 2025

ToxStudio®: In silico tools to accelerate toxicology assessments

Certara IQ™: The Scalable AI-Powered QSP Software

The Many Challenges of Patient Narrative Writing | RAPS Sponsored Webinar

Small Biotech Clinical Trial Application (CTA) & Investigational New Drug (IND) Submission Success with Integrated Project Management

BioTechX US 2025

Accelerate your SDTM Mapping with Pinnacle 21 Enterprise Plus

Population Pharmacokinetics for Belantamab Mafodotin Monotherapy and Combination Therapies in Patients with Relapsed/Refractory Multiple Myeloma

Sacituzumab Govitecan Population Pharmacokinetics: Updated Analyses Using HR+/HER2− Metastatic Breast Cancer Data From the Phase 3 TROPiCS‐02 Trial

Differences between eCTD 4.0 and eCTD 3.2.2 Submissions – What You Need to Know

Regulatory Operations Best Practices for Health Canada Submissions

Newsletter sign up

Quick links

Solutions

Contact